News | July 29, 2007

New Treatment Techniques for XKnife Radiosurgery Presented

July 30, 2007 - Users of Integra Radionics’ XKnife noninvasive radiosurgery presented their latest advances in the treatment of brain, spine and lung tumors at the recent AAPM meeting in Minneapolis, MN.

Dr. Satish Jaywant, associate professor of Radiation Oncology at Robert Wood Johnson University Hospital in New Brunswick, NJ presented his latest work using stereotactic immobilization, cone-beam CT, and the Integra Radionics ImageFusion software algorithms to achieve stereotactic accuracy for extracranial targets. Targets in the cervical, thoracic and lumbar spine, as well as the lung, were treated with the noninvasive XKnife Body Localizer.

Dr. Lu Wang, assistant professor of the Fox Chase Cancer Center in Philadelphia, PA, demonstrated the use of 4-D CT images, taken inside the simulation room, to account for target motion in lung tumors.

Dr. Jimm Grimm from Christiana Care Health Services in Newark,DE, presented a novel method of improving the accuracy of XKnife cranial radiosurgery to 0.2mm on most linear accelerators. Dr. Grimm's SAlinac, a work-in-progress system, uses automatic film test analysis and video registration of laser alignment, together with a wireless hand-held device, which provides real-time realignment advice as necessary.

For more information:

Related Content

Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Overall survival of metastatic patients with SABR presented at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018
News | Radiation Oncology | October 30, 2018
October 30, 2018 — In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggre
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
CyberKnife System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
News | Stereotactic Body Radiation Therapy (SBRT) | September 27, 2018
Accuray Inc. announced that published data from two prospective, multi-center studies using differing protocols provide...
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
Age Impacts Post-treatment Mortality for Early-stage Lung Cancer Patients

Image courtesy of Henri Becquerel Cancer Center

News | Stereotactic Body Radiation Therapy (SBRT) | January 24, 2018
A University of Colorado Cancer Center study published in the Journal of Clinical Oncology explores mortality in the...
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...